<SEC-DOCUMENT>0001683168-21-000815.txt : 20210309
<SEC-HEADER>0001683168-21-000815.hdr.sgml : 20210309
<ACCEPTANCE-DATETIME>20210308202724
ACCESSION NUMBER:		0001683168-21-000815
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20210308
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210309
DATE AS OF CHANGE:		20210308

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		21723730

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>radnet_i8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:RDNT="http://radnet.com/20210308">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_RDNT_radnet.com_20210308 -->
<!-- Field: Set; Name: xdx; ID: xdx_041_20210308_20210308_z181C45sF09f -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0000790526 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:EntityCentralIndexKey">0000790526</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="rdnt-20210308.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2021-03-08to2021-03-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-08</xbrli:startDate>
        <xbrli:endDate>2021-03-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 14pt"><b>UNITED
STATES </b></span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 14pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span><b> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 14pt"><b>FORM <span id="xdx_908_edei--DocumentType_c20210308__20210308_zQO08Tv3xne3"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:DocumentType">8-K</ix:nonNumeric></span>
</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span id="xdx_909_edei--DocumentPeriodEndDate_c20210308__20210308_zynqgoXCLqz9"> <ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">March 8, 2021</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 14pt"><b><span id="xdx_906_edei--EntityRegistrantName_c20210308__20210308_zWsVAGT86Fx3"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:EntityRegistrantName">RadNet,
Inc.</ix:nonNumeric></span></b></span><b> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 34%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 32%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 32%">&#160;</td></tr>
<tr>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20210308__20210308_zqQgoMZbY6s5"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_edei--EntityFileNumber_c20210308__20210308_zyab3uHP5odl"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:EntityFileNumber">001-33307</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20210308__20210308_zcodwLUsqG8"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:EntityTaxIdentificationNumber">13-3326724</ix:nonNumeric></span></span></td></tr>
<tr>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(State or other jurisdiction of incorporation)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(IRS Employer<br />
Identification Number)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_908_edei--EntityAddressAddressLine1_c20210308__20210308_z33nvzo1sEif"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:EntityAddressAddressLine1">1510 Cotner Avenue</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_904_edei--EntityAddressCityOrTown_c20210308__20210308_zKWdXOeTEF45"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:EntityAddressCityOrTown">Los Angeles</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressStateOrProvince_c20210308__20210308_zgO07GF0eRIk"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_90D_edei--EntityAddressPostalZipCode_c20210308__20210308_zF0cJACNsAD1"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:EntityAddressPostalZipCode">90025</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of
Principal Executive Offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_905_edei--CityAreaCode_c20210308__20210308_zUPJjOimh2od"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:CityAreaCode">(310)</ix:nonNumeric></span> <span id="xdx_909_edei--LocalPhoneNumber_c20210308__20210308_zYN2VfjYFqd5"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:LocalPhoneNumber">445-2800</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s Telephone
Number, Including Area Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Check&#160;the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see </i>General
Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-family: Wingdings"><span id="xdx_906_edei--WrittenCommunications_c20210308__20210308_z7qH4ttGKbXk"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 94%"><span style="font-family: Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-family: Wingdings"><span id="xdx_901_edei--SolicitingMaterial_c20210308__20210308_zjJWE7cDzbQ4"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 94%"><span style="font-family: Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-family: Wingdings"><span id="xdx_902_edei--PreCommencementTenderOffer_c20210308__20210308_z4qCNlWPxkKb"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 94%"><span style="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-family: Wingdings"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20210308__20210308_zVTyrsQrtnwf"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 94%"><span style="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 34%">&#160;</td>
    <td style="vertical-align: top; width: 33%">&#160;</td>
    <td style="width: 33%">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration: underline">Title of Each Class</span></span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration: underline">Trading Symbol(s)</span></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration: underline">Name of each exchange on which registered</span></span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_edei--Security12bTitle_c20210308__20210308_zrvN40GvzR3k"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:Security12bTitle">Common Stock, $.0001 par value</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_edei--TradingSymbol_c20210308__20210308_z4Ogh4WHG96g"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" name="dei:TradingSymbol">RDNT</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_edei--SecurityExchangeName_c20210308__20210308_z0qlWzCj7Wli"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <span style="font-family: Wingdings"><span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20210308__20210308_zpkAtR6ZuLK9"><ix:nonNumeric contextRef="From2021-03-08to2021-03-08" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<span style="font-family: Times New Roman, Times, Serif">
</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif"><b>Item 2.02</b></span></td>
    <td style="width: 90%"><b>RESULTS OF OPERATIONS AND FINANCIAL CONDITION</b></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 8, 2021 RadNet, Inc. (&#8220;RadNet&#8221;) issued a press release and held a conference call regarding our financial results
for the fourth quarter and year ended December 31, 2020. A copy of the press release is furnished as Exhibit 99.1 and a copy of the transcript
of the conference call is furnished as Exhibit 99.2 to this Current Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in
Item 2.02 of this Current Report, including Exhibit 99.1 and Exhibit 99.2 is being furnished and shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The
information in Item 2.02 of this Current Report, including Exhibit 99.1 and Exhibit 99.2 shall not be incorporated by reference
into any registration statement or other document filed with the Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif"><b>Item 9.01</b></span></td>
    <td style="width: 90%"><span style="font-family: Times New Roman, Times, Serif"><b>FINANCIAL STATEMENTS AND EXHIBITS.</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border: black 1pt solid; width: 16%"><span style="font-family: Times New Roman, Times, Serif"><b>Exhibit No.</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 84%"><span style="font-family: Times New Roman, Times, Serif"><b>Description</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-left: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-left: black 1pt solid">99.1</td>
    <td style="border-right: black 1pt solid"><a href="radnet_ex9901.htm">Press Release dated March 8, 2021 relating to RadNet, Inc.&#8217;s
financial results for the year ended December 31, 2020.</a></td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-left: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-left: black 1pt solid">99.2</td>
    <td style="border-right: black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-indent: -2.5in"><a href="radnet_ex9902.htm">Transcript of conference call.</a></p>
</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-left: black 1pt solid">&#160;</td>
    <td style="border-right: black 1pt solid">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">104</p></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cover Page Interactive Data File (embedded within the Inline
        XBRL document).</p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>
</b></span><b><span style="font-family: Times New Roman, Times, Serif">SIGNATURES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td><span style="font-family: Times New Roman, Times, Serif">Date: March 8, 2021</span></td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif">RadNet, Inc.</span></td></tr>
<tr style="vertical-align: top">
    <td style="width: 57%">&#160;</td>
    <td style="width: 6%">&#160;</td>
    <td style="width: 37%">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif">By:</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">/s/ Mark Stolper</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif">Name:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif">Mark Stolper</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif">Title:</span></td>
    <td>Chief Financial Officer</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LbObP+guHSriFBki3haXSXFrRtr580i+pXVDDIGQnPPlCDEQa1rpChnOizyDI9ZNpRxCjiUymgt6R7rZJuBnjldtHSvjuvUHpuQZ9MwkHCt/75x3bbFIQM6Go2gYS5DTRM7hsBPBV0/JlLpA47SqQJkCDkwNa3SKX/2Ho3qSofrVJZ2QrSaTQBTKXn5DLKMY9nRXD+KbhSxLRTDoKhBrprb5xrTWUQ3LCmufZXv038EH3+dJHQ== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>radnet_ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Exhibit 99.1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: black"><B><IMG SRC="image_001.jpg" ALT="New Radnet Logo - Color" STYLE="height: 90; width: 211"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR IMMEDIATE RELEASE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 12pt"><B>RadNet Reports Fourth Quarter
Results with Record Revenue and Adjusted EBITDA and Releases 2021 Financial Guidance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt; color: windowtext">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Despite the ongoing impact of COVID-19, RadNet reports record fourth
quarter 2020 Total Net Revenue (&ldquo;Revenue&rdquo;) of $308.5 million and Adjusted EBITDA<SUP>(<FONT STYLE="font-size: 10pt; color: black"><B>[1]</B></FONT>)</SUP>of
$50.7 million; Revenue increased 2.5% and Adjusted EBITDA<SUP>(1)</SUP> increased 8.1% as compared with the same quarter in 2019
</I></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt; color: windowtext">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Improved reimbursement from expanded implementation of 3D mammography
and increases in capitation contracts and cash collections drove increased Revenue</I></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt; color: windowtext">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Focus on cost reductions, center consolidations and operational
efficiencies throughout the COVID-19 period resulted in an Adjusted EBITDA<SUP>(1)</SUP> margin of 16.4%, an improvement of 0.8%,
or 80 basis points relative to last year&rsquo;s fourth quarter</I></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt; color: windowtext">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Adjusted Net Income<SUP>(3)</SUP></I></FONT><I>
<FONT STYLE="font-family: Times New Roman, Times, Serif">for the fourth quarter of 2020 was $10.2 million, or $0.20 per diluted
share as compared with $9.9 million, or $0.19 per diluted share for the same period in 2019</FONT></I></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt; color: windowtext">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>RadNet announces 2021 guidance ranges, anticipating material increases
in Revenue, Adjusted EBITDA<SUP>(1)</SUP> and Free Cash Flow from 2019 and 2020 levels</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>LOS ANGELES, California, March 8, 2021
&ndash; RadNet, Inc. (NASDAQ: RDNT),</B> a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic
imaging services through a network of 331 owned and/or operated outpatient imaging centers, today reported financial results for
its fourth quarter and full year ended December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Financial Results</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Fourth Quarter Report:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief
Executive Officer of RadNet, commented &ldquo;Despite a continuing impact from COVID-19, our results in the fourth quarter were
the strongest quarterly performance in our Company&rsquo;s history. The recovery we experienced in the third quarter continued
to gain momentum throughout the fourth quarter. Improved reimbursement from both private and capitated payers and our widespread
adoption of 3D mammography, or tomosynthesis, were responsible for our achieving the Revenue growth in the quarter. Our mammography
volume, alone, during the fourth quarter increased 11.7% from the fourth quarter of 2019. In addition, significant changes we made
during the COVID-19 period to reduce costs and refine our operating protocols contributed to our record Adjusted EBITDA<SUP>(1)</SUP>
and strong profitability during the quarter. This aggressive cost management resulted in Adjusted EBITDA<SUP>(1)</SUP> margin improvement
from 15.6% in 2019&rsquo;s fourth quarter to 16.4% during this fourth quarter.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Throughout the COVID-19 period,
we have focused on managing our liquidity and financial leverage. At year-end 2020, we had a cash balance of $102.0 million and
our net debt leverage ratio was reduced to under four times Adjusted EBITDA<SUP>(1)</SUP>, essentially the same leverage we had
at year-end 2019, prior to COVID-19. Our Days Sales Outstanding (DSOs) at December 31, 2020 was 36.2 days, the lowest in our Company&rsquo;s
history. I would like to thank our entire employee base, those on the front lines and those in support functions and in our corporate
office, for their tireless efforts during this global pandemic. These extraordinary efforts have helped secure the future of RadNet
and positioned our Company for growth and success in 2021 and beyond,&rdquo; Dr. Berger noted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Though 2020 was a challenging time
for all, RadNet was there to respond to the needs of its patients. I am proud of the resiliency of our business, and it is indicative
of the critical role we play in the healthcare delivery system of the markets in which we service,&rdquo; added Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2020, RadNet
reported Revenue of $308.5 million and Adjusted EBITDA<SUP>(1)</SUP> of $50.7 million. Revenue increased $7.7 million (or 2.5%)
and Adjusted EBITDA<SUP>(1)</SUP> increased $3.8 million (or 8.1%) from the fourth quarter of 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted Diluted Net Income Attributable
to RadNet, Inc. Common Stockholders (Adjusted Net Income<SUP>(3)</SUP>) for the fourth quarter of 2020 was $10.2 million, or $0.20
per diluted share as compared with $9.9 million, or $0.19 per diluted share for the same period in 2019. Net Income Attributable
to RadNet, Inc. Common Shareholders (&ldquo;Net Income&rdquo;) for the fourth quarter of 2020 was $6.0 million, or $0.11 per diluted
share. This compares to Net Income of $10.4 million, or $0.21 per diluted share, in the fourth quarter of 2019. These per share
values are based upon weighted average number of diluted shares outstanding of 52.2 million in the fourth quarter of 2020 and 50.6
million of diluted shares outstanding in the fourth quarter of 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: black">Affecting Net
Income in the fourth quarter of 2020 were certain non-cash expenses and non-recurring items including: $---2.3 million of non-cash
employee stock compensation expense; $2.7 million of severance paid in connection with headcount reductions related to cost savings
initiatives; $657,000 loss on the disposal of certain capital equipment; </FONT>$750,000 of non-cash gain from interest rate swaps;
$4.2 million loss on impairment of intangible assets associated with trade names the Company discontinued; $4.0 million gain on
the extinguishment of certain debt; <FONT STYLE="color: black">and $1.1 million of amortization of deferred financing costs and
loan discount related to our existing credit facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2020, as compared
with the prior year&rsquo;s fourth quarter, MRI volume decreased 1.8%, CT volume increased 2.4% and PET/CT volume decreased 2.8%.
Overall volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, decreased
0.5% over the prior year&rsquo;s fourth quarter. On a same-center basis, including only those centers which were part of RadNet
for both the fourth quarters of 2020 and 2019, MRI volume decreased 1.5%, CT volume increased 1.4% and PET/CT volume decreased
1.3%. Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other
exams, decreased 0.2% from the prior year&rsquo;s same quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Annual Report:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For full year 2020, RadNet reported Revenue
(inclusive of provider relief funding) of $1,098 million and Adjusted EBITDA<SUP>(1)</SUP> of $139.5 million. Revenue decreased
$56.1 million (or 4.9%) and Adjusted EBITDA<SUP>(1)</SUP> decreased $24.7 million (or 15.0%) as compared with 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net Loss for 2020 was $14.8 million, or
$(0.29) per diluted share. This compares to Net Income of $14.8 million, or $0.29 per diluted share, in 2019. These per share values
are based upon weighted average number of diluted shares outstanding of 50.9 million in 2020 and 50.2 million of diluted shares
outstanding in 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: black">Affecting Net
Income in 2020 were certain non-cash expenses and non-recurring items including: $---12.4 million of non-cash employee stock compensation
expense; $4.4 million of severance paid in connection with headcount reductions related to cost savings initiatives; $1.2 million
loss on the disposal of certain capital equipment; </FONT>$6.0 million of non-cash loss from interest rate swaps; $4.2 million
loss on impairment of intangible assets associated with trade names the Company discontinued; $4.0 million gain on the extinguishment
of certain debt; <FONT STYLE="color: black">and $4.4 million of amortization of deferred financing costs and loan discount related
to our existing credit facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2020, as
compared to 2019, MRI volume decreased 11.9%, CT volume decreased 6.8% and PET/CT volume decreased 4.1%. Overall volume, taking
into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, decreased 12.9% for the twelve
months of 2020 over 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>2021 Fiscal Year Guidance</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For its 2021 fiscal year, RadNet announces
its guidance ranges as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 72%">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 35%; text-align: justify">Total Net Revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 35%; text-align: justify">$1,250 million - $1,300 million</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Adjusted EBITDA</FONT><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$180 million - $190 million</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Capital Expenditures <SUP>(a)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$70 million - $75 million</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Cash Paid for Interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$39 million - $44 million</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Free Cash Flow Generation <SUP>(b)(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$60 million - $70 million</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">Net of proceeds from the sale of equipment, imaging centers and joint venture interests, and excludes
New Jersey Imaging Network capital expenditures.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Defined by the Company as Adjusted EBITDA</FONT><SUP>(1)</SUP> <FONT STYLE="font-size: 10pt">less
Capital Expenditures and Cash Paid for Interest. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 65%; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">Dr. Berger
noted, &ldquo;For the second half of 2020, we exceeded $600 million of Revenue and $96 million of Adjusted EBITDA</FONT><SUP>(1)</SUP><FONT STYLE="font-size: 10pt">.
This performance is the result of a strong recovery of our procedural volumes and the significant impact from cost reduction programs
we instituted throughout the COVID-19 period. Our guidance ranges for 2021 are built with this momentum in mind and the assumption
that our business will continue to strengthen as COVID-19 restrictions are lifted in the states in which we operate. We believe
there is upside to our guidance ranges, which could result from accretive tuck-in acquisitions we may complete during the year,
further benefit from the cost reduction measures implemented in 2020, increases in reimbursement from private and capitated payors
and the expansion of our joint venture initiatives. Additionally, achieving growth in the Arizona marketplace through our Dignity
Health joint venture will be a major focus throughout 2021, which could include both de novo centers as well as acquisitions.
In 2021, we will also complete our upgrade to 3D mammography and continued development of our AI solutions. Sometime around the
middle 2021, we hope to receive FDA approval for our initial mammography AI product submitted in the fourth quarter of 2020, and
we anticipate filing with the FDA for its review a second mammography AI offering by year end.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Conference Call for Today</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief
Executive Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call today, at
10:30 a.m. Eastern Time. During the call, management will discuss the Company's 2020 fourth quarter and year-end results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Conference Call Details:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: Monday, March 8, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Time: 10:30 a.m. ET</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dial In-Number: 800-437-2398</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">International Dial-In Number: 786-204-3966</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">There will also be simultaneous
and archived webcasts available at </FONT>http://public.viavid.com/player/index.php?id=143719 <FONT STYLE="font-size: 10pt">or
http://www.radnet.com under the &ldquo;About RadNet&rdquo; menu section and &ldquo;News &amp; Press Releases&rdquo; sub-menu of
the website. An archived replay of the call will also be available and can be accessed by dialing <FONT STYLE="color: black">844-512-2921
</FONT>from the U.S., or <FONT STYLE="color: black">412-317-6671 </FONT>for international callers, and using the passcode <FONT STYLE="color: black">8718718</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>About RadNet, Inc.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">RadNet, Inc. is the leading national provider of freestanding,
fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet
has a network of 331 owned and/or operated outpatient imaging centers. RadNet's core markets include California, Maryland, Delaware,
New Jersey, New York and Arizona. Together with affiliated radiologists, and inclusive of full-time and per diem employees and
technicians, RadNet has a total of approximately 8,300 employees. For more information, visit http://www.radnet.com.</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>Forward Looking Statements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">This press release contains &ldquo;forward-looking
statements&rdquo; within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.
Forward-looking statements are expressions of our current beliefs, expectations and assumptions regarding the future of our business,
future plans and strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can
generally be identified by words such as: &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;goal,&rdquo;
&ldquo;seek,&rdquo; &ldquo;believe,&rdquo; &ldquo;project,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;strategy,&rdquo;
&ldquo;future,&rdquo; &ldquo;likely,&rdquo; &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;will&rdquo; and similar references
to future periods. Forward-looking statements in this press release include, among others, statements we make regarding response
to and the expected future impacts of COVID-19, including statements about our anticipated business results, balance sheet and
liquidity and our future liquidity, burn rate and our continuing ability to service or refinance our current indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">Forward-looking statements are neither
historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently
subject to uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our
control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements.
Therefore, you should not place undue reliance on any of these forward-looking statements. Important factors that could cause our
actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among
others, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the ongoing impact of the COVID-19 pandemic
on our business, suppliers, payors, customers, referral sources, partners, patients and employees, including (i) government&rsquo;s
unprecedented action regarding existing and potential restrictions and/or obligations related to citizen and business activity
to contain the virus; (ii) the consequences of an economic downturn resulting from the impacts of COVID-19 and the possibility
of a global economic recession; (iii) the impact of the volume of canceled or rescheduled procedures, whether as a result of government
action or patient choice; (iv) measures we are taking to respond to the COVID-19 pandemic, including changes to business practices;
(v) the impact of government and administrative regulation, guidance and appropriations; (vi) changes in our revenues due to declining
patient procedure volumes, changes in payor mix; (vii) potential increased expenses or workforce disruptions related to our employees
that could lead to unavailability of key personnel; (viii) workforce disruptions related to our key partners, suppliers, vendors
and others we do business with; (ix) the impact of return to work orders in certain states in which we operate; and (x) increased
credit and collectability risks;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the availability and terms of capital
to fund our business;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to service our indebtedness,
make principal and interest payments as those payments become due and remain in compliance with applicable debt covenants, in addition
to our ability to refinance such indebtedness on acceptable terms;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in general economic conditions
nationally and regionally in the markets in which we operate;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the availability and terms of capital
to fund the expansion of our business and improvements to our existing facilities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to maintain our current credit
rating and the impact on our funding costs and competitive position if we do not do so;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">volatility in interest and exchange rates,
or credit markets;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the adequacy of our cash flow and earnings
to fund our current and future operations;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in service mix, revenue mix and
procedure volumes; </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">delays in receiving payments for services
provided;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">increased bankruptcies among our partner
physicians or joint venture partners;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the impact of the political environment
and related developments on the current healthcare marketplace and on our business, including with respect to the future of the
Affordable Care Act; </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the extent to which the ongoing implementation
of healthcare reform, or changes in or new legislation, regulations or guidance, enforcement thereof by federal and state regulators
or related litigation result in a reduction in coverage or reimbursement rates for our services, or other material impacts to our
business;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">closures or slowdowns and changes in labor
costs and labor difficulties, including stoppages affecting either our operations or our suppliers' abilities to deliver supplies
needed in our facilities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the occurrence of hostilities, political
instability or catastrophic events; </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the emergence or reemergence of and effects
related to future pandemics, epidemics and infectious diseases; and </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">noncompliance by us with any privacy or
security laws or any cybersecurity incident or other security breach by us or a third party involving the misappropriation, loss
or other unauthorized use or disclosure of confidential information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any forward-looking statement contained
in this current report is based on information currently available to us and speaks only as of the date on which it is made. We
undertake no obligation to publicly update any forward-looking statement, whether written or oral, that we may make from time to
time, whether as a result of changed circumstances, new information, future developments or otherwise, except as required by applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Regulation G: GAAP and Non-GAAP
Financial Information</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This release contains certain financial
information not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP metrics to measure its financial results.
The Company believes that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance.
The Company believes this information is useful to investors and other interested parties because it removes unusual and nonrecurring
charges that occur in the affected period and provides a basis for measuring the Company's financial condition against other quarters.
Such information should not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable
to other similarly titled measures of other companies. Non-GAAP financial measures should not be considered in isolation from,
or as a substitute for, financial information prepared in accordance with GAAP. Reconciliation of this information to the most
comparable GAAP measures is included in this release in the tables which follow.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>CONTACTS: </I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>RadNet, Inc.</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mark Stolper, 310-445-2800</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Executive Vice President and Chief
Financial Officer</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 406.5pt">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONSOLIDATED BALANCE SHEETS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center">As of December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">CURRENT ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 70%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">102,018</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">40,165</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Accounts receivable, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">129,585</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">154,763</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Due from affiliates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,836</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,242</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">32,985</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">45,004</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">270,424</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">241,174</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">399,335</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">367,795</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Operating lease right-of-use assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">483,661</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">445,477</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Total property, equipment and right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">882,996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">813,272</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">OTHER ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">472,879</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">441,973</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Other intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,393</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,994</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Deferred financing costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,767</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,559</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Investment in joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,528</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,470</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Deferred tax assets, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,687</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,548</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Deposits and other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">36,983</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">36,996</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,786,657</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,646,986</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center">LIABILITIES AND EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CURRENT LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Accounts payable, accrued expenses and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">236,684</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">207,585</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Due to affiliates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,010</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,347</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Deferred revenue related to software sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,257</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,316</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current portion of finance lease</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,578</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,283</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Current portion of operating lease</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,794</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61,206</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Current portion of notes payable and long term debt</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">39,791</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">39,691</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">398,114</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">327,428</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">LONG-TERM LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Finance lease, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">743</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,264</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Operating lease, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">463,096</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">420,922</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Notes payable, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">612,913</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">652,704</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Other non-current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">53,488</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,529</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,528,354</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,413,847</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">RadNet, Inc. stockholders' equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Common stock - $.0001 par value, 200,000,000 shares authorized; 51,640,044 and 50,314,328 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Additional paid-in-capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">307,788</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">262,865</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accumulated other comprehensive (loss) income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(24,051</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,026</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(117,999</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(103,159</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total RadNet, Inc.'s stockholders' equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">165,743</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">151,685</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">92,560</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">81,454</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">258,303</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">233,139</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total liabilities and equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,786,657</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,646,986</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;<BR STYLE="clear: both">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONSOLIDATED STATEMENTS OF OPERATIONS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center">Years Ended December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold">REVENUE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 55%; text-align: left; text-indent: -10pt; padding-left: 20pt">Service fee revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">931,722</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,028,236</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">868,741</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Revenue under capitation arrangements</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">140,118</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">125,943</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">106,405</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Total revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,071,840</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,154,179</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">975,146</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Provider relief funding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,264</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Cost of operations, excluding depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">965,902</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">999,692</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">867,547</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">86,795</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,607</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,899</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Loss (gain) on sale and disposal of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,200</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,383</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,054</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Loss on impairment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,170</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,937</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Severance costs</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,353</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,619</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,931</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,062,420</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,084,301</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">944,260</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">INCOME FROM OPERATIONS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,684</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">69,878</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,886</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">OTHER INCOME AND EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45,882</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,044</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,456</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Equity in earnings of joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,945</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,350</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,377</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Non-cash change in fair value of interest rate hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,528</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Gain on re-measurement of pre-existing interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(768</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(39,539</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Gain on extinguishment of debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,047</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Other expenses (income)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">120</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,283</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(181</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Total other expenses (income)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">36,538</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">40,209</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(7,641</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">(LOSS) INCOME BEFORE INCOME TAXES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(854</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,669</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,527</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(895</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(6,229</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(394</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">NET INCOME</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,749</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,440</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,133</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Net income attributable to noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">13,091</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,684</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,890</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(14,840</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">14,756</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">32,243</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.29</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.30</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.67</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.29</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.29</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.66</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-indent: -10pt; padding-left: 10pt">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt">Basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,891,790</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">49,674,858</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">48,114,275</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt">Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,891,790</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,244,006</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">48,678,999</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONSOLIDATED STATEMENTS OF CASH FLOWS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; </P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Years Ended December 31,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 55%; text-align: left; text-indent: -10pt; padding-left: 20pt">Net (loss) income</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(1,749</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">23,440</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">38,133</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Adjustments to reconcile net income&nbsp;to net cash provided by operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">86,795</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,607</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,899</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Amortization of operating right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67,915</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">66,842</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Equity in earnings of joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,945</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,350</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,377</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Distributions from joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,522</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,598</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,846</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Amortization and write off of deferred financing costs and loan discount</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,413</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,184</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,898</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Loss (gain) on sale and disposal of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,200</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,383</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,054</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Gain on extinguishment of debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,047</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Gain on re-measurement of pre-existing interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(768</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(39,539</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Loss on impairment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,170</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,937</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Amortization of cash flow hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,448</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Non-cash change in fair value of interest rate hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,528</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Stock-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,405</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,730</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,662</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Other non cash item in other expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">242</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(371</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Change in value of contingent consideration</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,123</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,749</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,206</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17,482</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,145</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,588</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,557</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,248</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,425</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,326</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,687</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Deferred taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(611</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,888</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,935</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(53,906</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(66,831</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Deferred rent</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,312</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,941</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,082</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(208</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Accounts payable, accrued expenses and other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">45,069</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">17,316</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">26,221</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Net cash provided by operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">233,759</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">104,322</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">116,754</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Purchase of imaging facilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(31,265</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(27,150</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(73,192</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Investment at cost</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(143</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,200</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Purchase of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(94,172</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(74,153</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(72,180</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from sale of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">828</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,160</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,575</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from sale of equity interest in a joint venture</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">132</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from sale of internal use software</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">248</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Nulogix return of capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">792</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Equity contributions in existing and purchase of interest in joint ventures</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,635</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(103</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(126,244</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(99,465</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(146,749</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Principal payments on notes and leases payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,562</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,494</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,072</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Payments on senior notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(43,296</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(40,742</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(33,830</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Additional deferred finance costs on revolving loan amendment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(741</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from debt issuance, net of issuance costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">97,144</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from Payment Protection Program</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Distributions paid to noncontrolling interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,985</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,057</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,427</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from sale of noncontrolling interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,275</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Contributions from noncontrolling partners</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,640</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from revolving credit facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">250,900</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">261,200</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">204,300</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Payments on revolving credit facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(250,900</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(289,200</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(176,300</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Purchase of non-controlling interests</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(200</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Proceeds from issuance of common stock upon exercise of options</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">75</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">20</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Net cash (used in) provided by&nbsp;&nbsp;financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(45,561</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">24,951</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(10,869</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">EFFECT OF EXCHANGE RATE CHANGES ON CASH</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(101</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(32</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(69</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61,853</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,776</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(40,933</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">CASH AND CASH EQUIVALENTS, beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">40,165</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">10,389</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">51,322</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">CASH AND CASH EQUIVALENTS, end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">102,018</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">40,165</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,389</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Cash paid during the period for interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">39,521</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">46,254</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">37,016</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Cash paid during the period for income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">533</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,884</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4,933</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONSOLIDATED STATEMENTS OF OPERATIONS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE DATA)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center">Three Months Ended</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold">REVENUE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 70%; text-align: left; padding-left: 10pt">Service fee revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">271,530</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">265,484</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Revenue under capitation arrangements</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">36,973</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">35,356</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Total revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">308,503</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">300,840</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Cost of operations, excluding depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">257,808</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">255,696</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,259</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,413</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Loss (gain) on sale and disposal of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">657</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">898</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Loss on impairment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,170</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Severance costs</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,706</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">564</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">287,600</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">277,571</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">INCOME FROM OPERATIONS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,903</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,269</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">OTHER INCOME AND EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,439</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,454</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Equity in earnings of joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,769</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,278</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Non-cash change in fair value interest rate hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,995</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Gain on re-measurement of pre-existing interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,273</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Gain on extinguishment of debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,047</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other expenses (income)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">367</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">13</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total other expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,995</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">7,916</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">INCOME BEFORE INCOME TAXES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,908</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,353</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Provision for from income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(5,925</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,673</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">NET INCOME</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,983</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,680</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Net income attributable to noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,028</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,283</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">NET INCOME
    ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,955</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,397</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">BASIC NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.12</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.21</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.11</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.21</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt">Basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">51,384,586</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">49,905,482</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt">Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">52,224,090</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,633,570</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center; background-color: white"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center; background-color: white"><B>RADNET,
INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center; background-color: white"><B>RECONCILIATION
OF GAAP NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON SHAREHOLDERS TO ADJUSTED EBITDA<SUP>(1)</SUP></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>(IN THOUSANDS)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center"><B>Three Months Ended</B></TD><TD><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; text-align: center"><B>December 31,</B></TD><TD STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><B>2020</B></TD><TD STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><B>2019</B></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 70%; text-align: left">Net Income Attributable to RadNet, Inc. Common Stockholders</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">5,955</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">10,397</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Provision for Income Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,925</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,673</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Interest Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,439</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,454</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Severance Costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,706</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">564</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Depreciation and Amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,259</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,413</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Non Cash Employee Stock Based Compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,260</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,767</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Loss on Sale and Disposal of Equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">657</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">898</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Other Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">367</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Non Cash (Gain) in Fair Value of Interest Rate Hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,995</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Loss on Impairment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,170</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus (Gain) on Extinguishment of Debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,047</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Plus (Gain) on Re-measurement of Pre-existing Interest</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,273</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-style: normal; padding-bottom: 2.5pt; padding-left: 10pt"><B>Adjusted EBITDA</B><FONT STYLE="font: normal 400 10pt Times New Roman, Times, Serif"><SUP>(1)</SUP></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">50,696</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">46,906</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center"><B>Fiscal Year Ended</B></TD><TD><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; text-align: center"><B>December 31,</B></TD><TD STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><B>2020</B></TD><TD STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD><TD STYLE="padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center"><B>2019</B></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 70%; text-align: left">Net Income (Loss) Attributable to RadNet, Inc. Common Stockholders</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(14,840</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">14,756</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Provision for Income Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">895</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,229</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Interest Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45,882</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,044</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Severance Costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,353</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,619</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Depreciation and Amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">86,795</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,607</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Non Cash Employee Stock Based Compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,405</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,730</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Loss on Sale and Disposal of Equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,200</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,383</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Other Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">120</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,283</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Non Cash Loss in Fair Value of Interest Rate Hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,528</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Loss on Impairment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,170</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Legal Settlements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,248</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus (Gain) on Extinguishment of Debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,047</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Plus (Gain) on Re-measurement of Pre-existing Interest</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(768</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: 400; font-style: normal; padding-bottom: 2.5pt; padding-left: 10pt"><B>Adjusted EBITDA</B><FONT STYLE="font: normal 400 10pt Times New Roman, Times, Serif"><SUP>(1)</SUP></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">139,461</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">164,131</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">SCHEDULE OF ADJUSTED EARNINGS AND EARNINGS PER SHARE <FONT STYLE="font: normal 700 10pt Times New Roman, Times, Serif"><SUP>(3)</SUP></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE DATA)</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center">Three Months Ended</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 70%; font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 11%; text-align: right">5,955</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; width: 11%; text-align: right">10,397</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Add severance costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,706</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">564</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Add loss on impairment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,170</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Subtract gain on re-measurement of pre-existing interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,273</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Subtract non-cash gain on swap valuation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,995</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Subtract gain on extinguishment of debt</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(4,047</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Total adjustments - loss (gain)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(709</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Subtract tax impact of Adjustments (i)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">217</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(184</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Tax effected impact of adjustments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">617</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(525</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Add non-recurring tax adjustment related to joint
    venture</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,639</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">TOTAL ADJUSTMENT TO NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON SHAREHOLDERS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,256</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(525</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">ADJUSTED NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,211</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">9,872</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,224,090</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,633,570</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">ADJUSTED DILUTED NET INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.20</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.19</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">(i) Tax effected using 26% blended federal and state effective tax rate.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">PAYOR CLASS BREAKDOWN</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Fourth Quarter</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 45%; text-align: left">Commercial Insurance</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">58.5%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Medicare</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20.5%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Capitation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.0%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Medicaid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Workers Compensation/Personal Injury</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.2%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">RADNET PAYMENTS BY MODALITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Fourth Quarter</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">2018</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 40%">MRI</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">34.8%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">35.4%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">35.8%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">35.2%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.9%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.6%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.9%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.5%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>PET/CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.6%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.6%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.7%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>X-ray</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.7%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.3%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.1%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.4%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Ultrasound</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.4%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.3%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.4%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.2%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Mammography</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.8%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.7%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.2%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.8%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Nuclear Medicine</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.1%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.9%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.7%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.9%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5.1%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Footnotes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>&nbsp;</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(1)</SUP> The Company defines Adjusted
EBITDA as earnings before interest, taxes, depreciation and amortization, each from continuing operations and excludes losses or
gains on the disposal of equipment, other income or loss, loss on debt extinguishments, bargain purchase gains and non-cash equity
compensation. Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling
interests in subsidiaries, and is adjusted for non-cash and extraordinary events which took place during the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted EBITDA is reconciled to its nearest
comparable GAAP financial measure. Adjusted EBITDA is a non-GAAP financial measure used as analytical indicator by RadNet management
and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt.
Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA
should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing
activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance
or liquidity. As Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying
methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(2)</SUP> As noted above, the Company
defines Free Cash Flow as Adjusted EBITDA less total Capital Expenditures (whether completed with cash or financed) and Cash Interest
paid. Free Cash Flow is a non-GAAP financial measure. The Company uses Free Cash Flow because the Company believes it provides
useful information for investors and management because it measures our capacity to generate cash from our operating activities.
Free Cash Flow does not represent total cash flow since it does not include the cash flows generated by or used in financing activities.
In addition, our definition of Free Cash Flow may differ from definitions used by other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Free Cash Flow should not be considered
a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation
or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement
data presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA
is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric,
as presented, may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(3)</SUP> The Company defines Adjusted
Earnings Per Share as net income or loss attributable to RadNet, Inc. common stockholders and excludes losses or gains on the disposal
of equipment, loss on debt extinguishments, bargain purchase gains, severance costs, loss on impairment, loss or gain on swap valuation,
gain on extinguishment of debt, unusual or non-recurring entries that impact the Company&rsquo;s tax provision and any other non-recurring
or unusual transactions recorded during the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted Earnings Per Share is reconciled
to its nearest comparable GAAP financial measure. Adjusted Earnings Per Share is a non-GAAP financial measure used as analytical
indicator by RadNet management and the healthcare industry to assess business performance. Adjusted Earnings Per Share should not
be considered a measure of financial performance under GAAP, and the items excluded from Adjusted Earnings Per Share should not
be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities
or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or
liquidity. As Adjusted Earnings Per Share is not a measurement determined in accordance with GAAP and is therefore susceptible
to varying methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other
companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>radnet_ex9902.htm
<DESCRIPTION>TRANSCRIPT OF CONFERENCE CALL
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 99.2</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>C O R P O R A T E P
A R T I C I P A N T S</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper, </B><I>Executive Vice
President and Chief Financial Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger, </B><I>Chairman,
President and Chief Executive Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>C O N F E R E N C E
C A L L P A R T I C I P A N T S</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut, </B><I>Jefferies</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal, </B><I>Sidoti &amp;
Co. LLC</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Jonathan Ransom, </B><I>Raymond James</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>P R E S E N T A T I
O N</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good day, and welcome to the RadNet Inc.
Q4 and Full-Year 2020 Financial Results Call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Today&rsquo;s conference is being recorded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I would like to turn the
conference over to Mr. Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, Inc. Please go ahead, sir.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good morning, ladies and gentlemen, and
thank you for joining Dr. Howard Berger and me today to discuss RadNet&rsquo;s Fourth Quarter and Full-Year 2020 Financial Results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before we begin today, we&rsquo;d like
to remind everyone of the Safe Harbor statement under the Private Securities Litigation Reform Act of 1995. This presentation contains
forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements
concerning anticipated future financial and operating performance; RadNet&rsquo;s ability to continue to grow the business by generating
patient referrals and contracts with radiology practices; recruiting and retaining technologists; receiving third-party reimbursement
for diagnostic imaging services; successfully integrating acquired operations; generating revenue and Adjusted EBITDA for the acquired
operations as estimated, among others, are forward-looking statements within the meaning of the Safe Harbor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forward-looking statements are based on
Management&rsquo;s current preliminary expectations and are subject to risks and uncertainties which may cause RadNet&rsquo;s actual
results to differ materially from the statements contained herein. These risks and uncertainties, including those risks set forth
in RadNet&rsquo;s reports filed with the SEC from time to time, including RadNet&rsquo;s Annual Report on Form 10-K for the year
ended December 31, 2020, to be filed shortly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Undue reliance should not be placed on
forward-looking statements, especially guidance on future financial performance which speaks only as of the date it is made. RadNet
undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances
after the date they were made, or to reflect the occurrence of unanticipated events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that, I&rsquo;d like to turn the call
over to Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good morning, everyone, and thank you for
joining us today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On today&rsquo;s call, Mark and I plan
to provide you with highlights from our fourth quarter and full-year 2020 results, give you more insight into the factors which
affected this performance and discuss our future strategy. After our prepared remarks, we will open the call to your questions.
I&rsquo;d like to thank all of you for your interest in our Company and for dedicating a portion of your day to participate in
our conference call this morning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before we start, I would like to say on
behalf of myself and the entire team at RadNet, we hope all of you and your loved ones are healthy and staying safe. We are extremely
grateful for all of our stakeholders, including our employees, business partners, lenders and shareholders, and wish you all well
during this challenging time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Let&rsquo;s begin. I am very pleased with
our performance in the fourth quarter. Continuing with the recovery of our procedural volumes that began in the third quarter,
we recorded the highest quarterly revenue and Adjusted EBITDA in the Company&rsquo;s history this fourth quarter. The turnaround
of our business has been quite remarkable, from its low point in mid-April when our procedural volumes dropped by 72% from pre-COVID
levels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the fourth quarter, our revenue grew
by 2.5%, which was the result of several factors. First, during 2020, we significantly expanded our 3D mammography program on both
coasts. As a result, our mammography volumes increased by 11.7% during the fourth quarter, relative to the same quarter in 2019.
Much of the increase in mammography volumes brought an associated reimbursement premium for the tomosynthesis 3D technology. Second,
the increased revenue was the result of reimbursement increases from private and capitated payers, as well as improved collections,
particularly around patient co-payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the record revenue performance,
our Adjusted EBITDA in the fourth quarter of 2020 was $50.7 million, as compared with $46 million in the fourth quarter of 2019,
an increase of 8.1%. While the increase in revenue contributed to the growth in Adjusted EBITDA, the improved Adjusted EBITDA performance
was also the result of cost saving measures we instituted during the COVID-19 period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the onset of COVID-19, we aggressively
focused on reducing expenses, consolidating underperforming sites and changing key operational metrics, both at the center level
and within our corporate support departments. The operational improvements we made will continue to benefit the business into the
future and are reflected in the 2021 guidance ranges we announced earlier today in our financial results press release. From a
margin perspective, our Adjusted EBITDA margin was 16.4% in the fourth quarter of 2020, as compared with 15.6% in the fourth quarter
of 2019, an improvement of 0.8% or 80 basis points.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our adjusted earnings were also very strong.
Adjusted for one-time and extraordinary events during the quarter, our adjusted net income was $10.2 million or $0.20 per diluted
share, as compared with $9.9 million or $0.19 per diluted share in the fourth quarter of 2019. Throughout the COVID-19 period,
we have focused on strengthening our balance sheet by managing our liquidity and financial leverage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At year-end 2020, we had a cash balance
of $102 million and our net debt leverage ratio was reduced to under four times Adjusted EBITDA, a little similar to that of year-end
2019 prior to the onset of COVID-19. We believe that our strong balance sheet positions us to be aggressive in 2021 with respect
to growth initiatives, and will include tuck-in acquisitions, de novo centers and continued capital spending to drive same-center
performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While it is noteworthy to highlight the
strong financial performance of our last three quarters as our business began to recover from the worst of COVID-19 impact throughout
2020, we made some significant progress in furthering our long-term operating plan. Here are some of the highlights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March of 2020, we completed our acquisition
of DeepHealth, a leading artificial intelligence and machine learning company, initially focused on solutions for the medical interpretation
of mammography exams. DeepHealth&rsquo;s development has focused on screening mammography, specifically 3D breast imaging, where
the large volume of cases and the difficult nature of their interpretation placed significant demand on radiologists. We are more
certain today than ever before that artificial intelligence will transform the diagnostic imaging and radiology industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Machine learning, big data applications
and automation algorithms will allow us to deliver our services more cost effectively, efficiently and accurately. We spend almost
20% of our globally billed net revenue to the radiologist&rsquo;s interpretation of our images. We believe AI will create workflow
efficiencies and can improve the accuracy of image interpretation in mammography and in other modalities we perform, which can
materially benefit all of our RadNet stakeholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the fourth quarter of 2020, we submitted
for FDA approval of our first AI mammography product, which is a screening triage product for radiologists. We hope to receive
approval sometime towards the middle of the year. By the end of the year, we anticipate submitting for FDA approval in a secondary
product for more advanced mammography diagnostics, and look forward to keeping you informed with our progress on these fronts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Related to our DeepHealth acquisition,
in August of 2020, we announced a collaboration with Hologic to advance the development of artificial intelligence tools in breast
health. The collaboration will enable new joint market opportunities and further efforts to build clinician confidence and develop
and integrate new AI technologies. As part of the collaboration, RadNet has been upgrading its entire fleet of Hologic mammography
systems to feature the Hologic Clarity HD and Quorum 3D imaging technologies, and we&rsquo;ll share with Hologic certain data produced
by RadNet&rsquo;s suite of high-resolution mammography systems.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2020, we furthered the expansion of
our health system joint venture businesses. In October, we established a partnership with Adventist Health to create an outpatient
imaging joint venture in Simi Valley, California, to initially include three outpatient facilities. In addition, we assumed operational
management of Adventist Health&rsquo;s Nancy Reagan Breast Center. Also in October, RadNet announced its third joint venture, with
Dignity Health, CommonSpirit in Phoenix, Arizona, initially established with eight acquired facilities. We plan to significantly
expand our offerings in the Greater Phoenix Area in the coming years through a combination of new site development and the acquisition
of existing radiology providers. The process of expansion has begun and we anticipate allocating significant focus and financial
and management resources on this new market over the coming years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August of 2020, we completed an amendment
to our credit agreement to increase the amount of the revolving commitments thereunder by $57.5 million to a total of $195 million.
While this was done out of an abundance of precaution and a concern for our liquidity position during the global pandemic, the
expansion of our available credit position allows us to have funds at our disposal to grow the Company more aggressively in the
coming years, and are available for accretive acquisitions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I&rsquo;d like to turn the
call back over to Mark to discuss some of the highlights of our fourth quarter and full 2020 performance. When he is finished,
I will make some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Howard.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;m now going to briefly review our
fourth quarter and full-year 2020 performance, and intend to highlight what I believe to be some material items. I will also give
some further explanation of certain items in our financial statements, as well as provide some insights into some of the metrics
that drove our fourth quarter and full-year 2020 performance. I will also provide 2021 financial guidance levels, which were raised
in this morning&rsquo;s financial results press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In my discussion, I will use the term Adjusted
EBITDA, which is a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation
and amortization, and excludes losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishments
and non-cash equity compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted EBITDA includes equity and earnings
in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted
for non-cash or extraordinary and one-time events taking place during the period. A full quantitative reconciliation of Adjusted
EBITDA to net income or loss attributable to RadNet, Inc. common shareholders is included in our earnings release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that said, I&rsquo;d now like to review
our fourth quarter and full-year 2020 results. For the three months ended December 31, 2020, RadNet reported revenue of $308.5
million and Adjusted EBITDA of $50.7 million. Both were the highest quarterly levels in our Company&rsquo;s history. Revenue increased
$7.7 million or 2.5% over the prior-year same quarter, and Adjusted EBITDA increased $3.8 million or 8.1% over the prior-year same
quarter. The increase in revenue and Adjusted EBITDA was the result of a combination of better reimbursement from the expansion
of our 3D mammography offerings, improved reimbursement from private and capitated payers, enhanced cash collections and significant
cost reductions, as detailed by Dr. Berger in his earlier remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2020, as compared
with the prior-year&rsquo;s fourth quarter, aggregate MRI volume decreased 1.8%, CT volume increased 2.4% and PET CT volume decreased
2.8%. Overall volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, decreased
0.5% over the prior-year&rsquo;s quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the fourth quarter of 2020, we performed
1,977,086 total procedures. The procedures were consistent with our multimodality approach, whereby 76.7% of all the work we did
by volume was from routine imaging. Our procedures in the fourth quarter of 2020 were as follows. Note that the CT volumes for
2019 have been restated to account for a change we made as of January 1 of 2020 in how we account for one of our CT CPT codes.
The comparative numbers that follow are on an apples to apples basis: 276,482 MRIs, as compared with 281,646 MRIs in the fourth
quarter of 2019; 172,728 CTs, as compared with 168,706 CTs in the fourth quarter of 2019; 11,063 PET CTs, as compared with 11,381
PET CTs in the fourth quarter of 2019; and 1,516,813 routine imaging exams, compared with 1,524,608 of all these exams in the fourth
quarter of 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted net income, which is net income
adjusted in each period for one-time or extraordinary items, was $10.2 million for the fourth quarter of 2020 or $0.27 per diluted
share, as compared with $9.9 million or $0.19 per diluted share for the same period in 2019. These per-share values are based upon
weighted average number of diluted shares outstanding of 52.2 million shares in the fourth quarter of 2020, and 50.6 million shares
outstanding in the fourth quarter of 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Affecting net income in the fourth quarter
of 2020 were certain noncash expenses and nonrecurring items, including the following: $2.3 million of noncash employee stock compensation
expense; $2.7 million of severance paid in connection with headcount reductions related to cost savings initiatives; $657,000 loss
on the disposal of certain capital equipment; $750,000 of noncash gain from interest rate hedges; $4.2 million loss on the impairment
of intangible assets associated with trade names the Company has discontinued; $4 million gain on the extinguishment of certain
debt; and $1.1 million of amortization of deferred financing costs and loan discounts related to our existing credit facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regards to some specific income statement
accounts, overall GAAP interest expense for the fourth quarter of 2020 was $12.4 million. This compares with GAAP interest expense
in the fourth quarter of 2019 of $11.5 million. Cash paid for interest during the period, which excludes noncash deferred financing
expense and accrued interest, was $8.3 million, as compared with $10.2 million in the fourth quarter of last year. For the full-year
of 2020, the Company reported $1,098,104,000 of revenue, which is inclusive of $26.2 million of provider relief funding we received
under the CARES Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted EBITDA was $139.5 million and
net loss was $14.8 million. Due to the impact of COVID-19, revenue decreased $56.1 million or 4.9%, and Adjusted EBITDA decreased
$24.7 million or 15%, as compared with 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2020, as
compared with 2019, MRI volume decreased 11.9%, CT volume decreased 6.8% and PET CT volume decreased 4.1%. Overall volume, taking
into account all routine imaging, decreased 12.9% for the 12 months of 2020, as compared with 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2020, we performed 6,867,021 total procedures.
The procedures were consistent with our multimodality approach, whereby 76.1% of all the work we did by volume was from routine
imaging. Our procedures in 2020 were as follows. Again, like the assumption of the comparison of the fourth quarter procedural
volume, the CT volumes for 2019 have been restated to account for a change we made as of January 1, 2020 in how we account for
one of our CT CPT codes. The comparative numbers that follow are also on an apples to apples basis: 976,633 MRIs, compared with
1,108,496 MRIs in 2019; 620,547 CTs, as compared with 665,539 CTs in 2019; 41,567 PET CTs, as compared with 43,341 PET CTs in 2019;
and 5,228,274 routine imaging exams, as compared with 6,068,928 of all these exams in 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net loss for 2020 was $14.8 million or
negative $0.29 per diluted share. This compares to net income of $14.8 million or $0.29 per diluted share in 2019. These per-share
volumes are based on weighted average number of diluted shares outstanding of 50.9 million shares in 2020 and 50.2 million shares
in 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Affecting net income in 2020 were certain
noncash expenses and nonrecurring items, including the following: $12.4 million of noncash employee stock compensation expense;
$4.4 million of severance paid in connection with headcount reductions related to cost savings initiatives; $1.2 million loss on
the disposal of certain capital equipment; $6 million of noncash loss from interest rate hedges; $4.2 million loss on the impairment
of intangible assets associated with trade names the Company has discontinued; $4 million of gain on the extinguishment of certain
debt; and $4.4 million of amortization of deferred financing costs and loan discounts related to our existing credit facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regards to some specific income statement
accounts, overall GAAP interest expense in 2020 was $45.9 million. Adjusting for the noncash impact from items such as amortization
of financing fees and accrued interest, cash interest expense was $39.5 million in 2020. This compares with GAAP interest expense
in 2019 of $48 million and cash paid for interest of $46.3 million in 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regards to our balance sheet, as of
December 31, 2020, unadjusted for bond and term loan discounts, we had $563.7 million of net debt, which is total debt at par value
less our cash balance. Note that this debt balance includes New Jersey Imaging Network&rsquo;s debt of approximately $53 million,
for which RadNet is neither a borrower nor guarantor. This compares with $672.4 million of net debt at December 31, 2019. As of
year-end 2020, we were undrawn on our $195 million revolving line of credit and had a cash balance of $102 million, which was substantially
up from $40.2 million cash balance at year-end 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At December 31, 2020, our accounts receivable
balance was $129.6 million, a decrease of $25.2 million from year-end 2019. The decrease in accounts receivable is mainly from
improved cash collections, including additional efforts and resources dedicated to patient collections at the time of service.
Our DSO was 36.2 days at December 31, 2020, lower by 8.5 days when compared with 44.7 days as of that date one year earlier.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Throughout 2020, we had total capital expenditures
net of asset dispositions and the Seattle Imaging Center assets and joint venture interests of $86 million. This amount excludes
$7.4 million of capital expenditures of New Jersey Imaging Network. Approximately all of our capital expenditures were paid for
in cash, and we recognized $828,000 in proceeds from the sale of equipment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capital expenditures in 2020 were higher
than we originally budgeted as a result of additional investments we made in 3D mammography capacity, in conjunction with the Whiterabbit.ai
rollout and some opportunities we saw to take market share away from some of our competitors in selected markets during the COVID-19
period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I&rsquo;d like to review
our 2021 Fiscal Year guidance levels which we released this morning in our financial results press release. For total net revenue,
our guidance range is $1.25 billion to $1.3 billion. For Adjusted EBITDA, our guidance range is $180 million to $190 million. For
capital expenditures, our guidance range is $70 million to $75 million. For cash paid for interest, our guidance range is $39 million
to $44 million. For free cash flow generation, which we define as our Adjusted EBITDA less capital expenditures, less cash paid
for interest, our guidance range is $60 million to $70 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These guidance levels are built on a number
of assumptions. First, we entered 2021 on the strength of a strong recovery from COVID-19, as indicative of our performance levels
during the second half of 2020. For the second half of 2020, we exceeded $600 million of revenue and $96 million of Adjusted EBITDA.
Our guidance ranges for 2021 are built with this run rate in mind, and the assumption that our business will continue to strengthen
as COVID-19 restrictions are lifted in the states in which we operate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe there is upside to our guidance
ranges, which could result from accretive tuck-in acquisitions we expect to complete during the year, further benefit from the
cost reduction measures implemented in 2020, increases in reimbursement from private and capitated payers and the expansion of
our joint venture initiatives. Additionally, achieving growth in the Arizona marketplace through our Dignity Health joint venture
will be a major focus throughout 2021, which could include both de novo centers as well as acquisitions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2021, we will also complete our upgrade
to 3D mammography and continued development of our AI solutions. Sometime around the middle of 2021, we hope to receive FDA approval
for our initial mammography AI product submitted in the fourth quarter of 2021; and we anticipate filing with the FDA for its review,
a second mammography AI offering by year-end.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I now would like to turn the call back
over to Dr. Berger, who will make some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In conclusion, the challenges encountered
during the COVID-19 pandemic created a seminal event for RadNet. COVID-19 required us to re-evaluate every aspect of our business,
a business that has grown primarily in the past through acquisitions. COVID-19 allowed us to pause and analyze all of our procedures
and processes in order to achieve more optimal performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The pandemic also gave us the opportunity
to make decisions that would otherwise have proven more difficult in more normal times. We were able to consolidate some of our
centers that were in close proximity to other centers in ways that preserve patient access, convenience and our procedural volume.
The regional centralization of our scheduling departments and preauthorization teams afforded us the ability to more effectively
manage our capacity without losing business or negatively impacting our customer service. In addition, we were able to exit noncore
businesses and activities that were distracting our management teams from more core functions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we now approach the end of the first
quarter of 2020, we are optimistic for the remainder of the year. In particular, we look to make substantial progress in deploying
artificial intelligence in our business, especially with regards to screening mammography. These AI tools should improve our diagnostic
accuracy and result in earlier disease detection and better compliance amongst patients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are also working diligently to expand
a number of our health system joint ventures and seek to establish new ones. Our strong cash position at the end of 2020 leading
into this year, along with the availability of our $195 million revolving credit facility, will provide us with financial capabilities
to pursue accretive strategic acquisitions and execute on all of the facets of our operating plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operator, we are now ready for the question-and-answer
portion of the call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. We&rsquo;ll take our first question
from Brian Tanquilut with Jefferies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hi, good morning, guys, congratulations
on a good quarter and obviously a tough year, so congrats on navigating all that.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I guess my first question, for both of
you guys, Howard and Mark, as I look at the numbers that you posted in the quarter, obviously it looks like you&rsquo;ve seen a
good bit of recovery already. Mark, I appreciate you mentioning the conservatism of guidance, but how are you thinking about the
recovery that&rsquo;s remaining, or the opportunity remaining to see volumes pick up through pent-up demand? What kind of cadence,
over the course of the year, are you embedding in your guidance as it pertains to that?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good morning, Brian, and thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think there were a number of issues that
occurred in 2020 that will continue to help drive volumes into our centers, along with normal efforts that we make from a marketing
and contracting standpoint and just what has traditionally been a 2% to 3% annual organic growth in volumes. Notably, the pandemic
has created an additional effort on the part of payors to further encourage and help direct business away from hospitals. A number
of the major payors have either re-iterated or announced their reimbursement preferences for outpatient imaging centers, to the
point where they may not pay for some of the routine imaging that are done in hospital systems, both at not only higher cost, but
now with the pandemic still upon us, a less comfortable place for patients to go. We believe both of those issues will create additional
volume directed to outpatient facilities in general, and in ours in particular.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to that, it&rsquo;s clear that
some of our recovery to more normal volumes, and in fact having exceeded that so far in the early part of this year, is delayed
treatment and doctor visits that were put upon everybody in 2020. Notably, during the last nine months of 2020, many health systems
went to the extent of not performing elective procedures, which is one of the reasons why our MRI volume and others were affected
so much. We expect those to be lifted. Most of the health systems have already done that, but we expect that that additional need
for these essential services will be resurrected in 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Alongside of that, we believe that the
additional volume that will come to us will be a result of people preferring to go to the outpatient and ambulatory centers, along
with the fact that there are more articles appearing in the literature that delayed healthcare leads to greater cost and more bidding
(phon) in the system. I think all of those factors will help drive our revenues and are somewhat factored into our guidance for
2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, appreciate that. Then I guess, Howard,
while I have you, obviously mammography is an area that you&rsquo;ve been focused on and you&rsquo;ve talked about AI a little
bit in that space. Can you just walk me through what the strategy is there, and what sort of investments and expansion that we
should be watching out for going forward?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. Well, I think the primary reason
why we&rsquo;re focused on mammography is that, depending upon whose articles you read or which statistics, the marketplace does
not do a particularly good job at this time in the compliance for our patients to get their annual or biannual mammogram. We&rsquo;ve
begun, both through our Whiterabbit relationship, as well as some of our own internal measurements and analytics, to reach out
to patients and improve that compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, there&rsquo;s an estimate
that anywhere from perhaps as much as 30% to maybe even 50% or 60% of all women who should be getting mammography are not. Therefore,
since there&rsquo;s about 40 million mammograms done annually, there&rsquo;s a good argument to believe that, perhaps, 20 million
to 30 million more mammograms should be done on an annual basis. We believe that, given the scale that we have and the analytics
that we&rsquo;re capable of using to drive better compliance and reach out to first-time women getting the mammograms after the
age of 40, will help drive that business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To that end, as I mentioned in my remarks,
we have gone through a significant upgrading of our mammography systems through a relationship with Hologic, to not only get to
the 3D tomosynthesis throughout our entire fleet, but to elevate to their newest technology with high-resolution detectors and
faster and better management for reading the scans. We hope to couple that with the continued effort in our artificial intelligence
through the DeepHealth division, which, in an article that we published back in November, demonstrated that artificial intelligence
is able to detect breast cancer one to two years earlier than even some of the most qualified mammographers are capable of doing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think all of those give us a good reason
to think that our mammography, which was up as we reported, even in the fourth quarter, up almost 12%, has that opportunity to
continue in 2021. I also want to mention that, in most households, the mother or women are very much the determinant of where healthcare
is accessed by the rest of their family, so encouraging more and more of that mammography business, we believe, will also help
us with other downstream imaging and procedures that we can do in our centers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay, that makes a lot of sense. Then I
guess shifting gears, Howard, you obviously entered the Arizona market from the JV with Dignity. How should we be thinking about
your expansion plans there? You expanded the credit facility, so should we be thinking that you&rsquo;d be acquiring more in that
market specifically, or are you open to further expansion from a geographic footprint perspective?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think we&rsquo;ll be doing both, Brian.
We already have designs on at least two new imaging facilities that&rsquo;ll be on campuses of two of the largest Dignity Health
systems. We are in conversation with other medical groups that are closely aligned with Dignity about helping to manage their imaging
in a more effective way and driving business into the joint venture. We believe that there are acquisition opportunities that are
available to us to expand our footprint and have similar kind of opportunities and results like we&rsquo;ve experienced in other
markets that we&rsquo;ve entered. The best example of that being when we entered the New York metropolitan marketplace, believe
it or not, it&rsquo;s eight years ago at this point, we have become the largest operator of independent freestanding imaging facilities,
and a lot of our growth opportunities and improved performance are based on those kind of metrics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phoenix, which has, I think, a population
of well over five million people, has some very attractive and unique situations for us. As I&rsquo;ve mentioned in prior earnings
calls and conferences, the opportunity for us to enter new markets will follow the pattern that we&rsquo;ve demonstrated over the
last couple of years of expanding it with joint venture partners with large health systems. I think the investment and involvement
in Phoenix very much fits that profile.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Got it. Mark, last question for me. How
are you thinking about the sustainability of the margins, because they were obviously very strong within the quarter? I know you&rsquo;ve
laid out your cost initiatives, but just your quick thoughts on that. Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sure. With the initiatives that we completed
in 2020 in evaluating, really, every aspect of how we do business, both at the regional levels, the center levels, as well as in
all of the corporate support functions, we did pull significant amounts of cost out of our cost structure that will certainly impact
margins positively here in 2021. Having over a 16% margin in the fourth quarter was a significant improvement, not only over the
prior year but over prior quarters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect, if you look at our guidance
and look at the implied margin there, we expect to have somewhere around 15% blended margins for 2021. Why that&rsquo;s a little
bit lower than the fourth quarter here is there is some seasonality, as you&rsquo;re well aware, Brian, in our business, with respect
to first quarter. There&rsquo;s always some seasonality related to weather conditions in the Northeast, as well as the issue with
deductibles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Having said that, we&rsquo;ve had a robust
start, other than some of these weather conditions here, in the first quarter of 2021. We do expect the margin enhancement here
in 2021, I would even say versus 2019, because 2020 is not a good year to compare to because of COVID, where our margin was incredibly
depressed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think there&rsquo;s some real good opportunity
for margin enhancement. Also, as we adopt AI technology, particularly around mammography, and then develop or license other AI
technologies for other modalities into the future, we have the ability to make our radiologists more productive, potentially use
fewer radiologists and lower the cost significantly of delivering the professional interpretation of our scans. That could be a
real game changer into the future with respect to our margins.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Awesome. Thanks, guys.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Brian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We&rsquo;ll go to our next question, from
Mitra Ramgopal with Sidoti.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, good morning and thanks for taking
the questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I just wanted to follow-up on the AI comments
earlier. Obviously, it seems like you&rsquo;re getting some nice traction on the mammography side and with the FDA approval likely
and the upgrade to 3D. I was just wondering if the AI platform could be expanded to areas beyond mammography for you?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good morning, Mitra.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes. There&rsquo;s four core areas that
we think, as an outpatient provider, that primarily, as we see a shift of population health, will be beneficial not just for the
Company, but hopefully for the populace.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you look at the various cancers that
are most significant in volume, you deal with breast cancer, prostate cancer, lung cancer and colon cancer. Those account for about
80% of all the cancers. Each of those have screening tools that exist right now that, I believe, can be demonstrably improved through
application of artificial intelligence. We&rsquo;ve already demonstrated some of that and have indeed put our capital to work as
regards to mammography. Once we get some good traction on that, we can and are already looking at some initiatives for at least
prostate, along with colon and lung cancers down the road.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We think if anything, that can serve as
a great tool for putting some definition behind what population health means. We believe that diagnostic imaging will be at the
forefront of that, and that tools in these areas can have a very prominent effect on both diagnosing earlier as well as, and obviously
leading to, lower costs and reduced mortality. We think it&rsquo;s incumbent upon us as the leader in this industry, as well as
just generally what&rsquo;s good for the population, to focus our attention on these tools and provide programs for the health
insurers as well as employers to give some real meaning and definition to population health.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay, thanks, that&rsquo;s very helpful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Howard, I know you had talked earlier about
the increasing preference of payors to shift some of these procedures to the outpatient setting. I&rsquo;m just wondering if that&rsquo;s
also leading now to increased conversations or opportunities as it relates to more JVs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think it is. These are slow to develop
and take a long time. The health systems are large; to get their attention as well as deal with other local and geographic issues
takes a lot of work. But we think that the marketplace is ready for this. I think in a very specific way, COVID has helped focus
people&rsquo;s attention on that, given that the general healthcare consumer is more reluctant to go into a hospital or health
system today if they have the availability of comparable or even better access to outpatient imaging. I think more and more of
the hospital systems are recognizing the need to make this shift, in addition to issues related to reimbursement, we can focus
on a more strategic relationship and an approach to population health. I think we&rsquo;re getting a lot of good conversation surrounding
these opportunities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Again, I think RadNet is unique in terms
of the number of centers it has at our own joint ventures. As we&rsquo;ve mentioned before, over 25% of our centers now are in
joint ventures and we look eagerly to expand that number as we go forward, given that, I think, the joint venture arrangement affords
a lot of opportunity for both long-term stability and growth initiatives with our healthcare systems. I&rsquo;d be loathe if I
didn&rsquo;t mention here that during the COVID period one of the additional benefits from our joint ventures was that all of our
health systems reached out to us and afforded RadNet employees the opportunities to get their vaccinations for COVID as part of
the frontline essential healthcare workers. While that is not necessarily an easily monetized benefit, it was a significant benefit
to the RadNet employees that gave them the comfort and the confidence to continue to provide these services, which clearly has
now been identified as an essential service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think these initiatives and the benefits
that they provide were more demonstrated during the COVID period than perhaps at any other time in our history.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. Thanks for the additional color.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Then quickly on the capitation business,
if you can offer in terms of&mdash;what are you thinking about that? Obviously, despite the pandemic, you saw a really nice growth
there, and I&rsquo;m just wondering if we should continue to expect elevated top line in that piece of the business going forward,
near term?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, I believe that will be the case, Mitra.
Particularly out here in California where we had the greatest penetration in capitation, I think more and more of our medical groups
and related insurers are looking at not just capitation, but potentially new risk-sharing models that, given our geographic access
and the breadth of services we offer, are exciting propositions. Hopefully you&rsquo;ll be hearing more about that later this year,
with initiatives that may not be conventional in terms of what we have traditionally been doing in the way of capitation, but expanding
the potential reimbursement models that may move a little bit further away from the traditional fee-for-service. Again, I think
RadNet&rsquo;s in a unique position to do those, for a lot of the reasons that we&rsquo;ve already talked about.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes. I&rsquo;ll add that, during 2020,
our capitation business was really a shining star. Unlike the other books of business that we had that were significantly impacted
from COVID-19, i.e., the fee-for-service business, our capitated revenue was up over $14 million from 2019. That was really because
the enrolment in these HMO programs was stable and even slightly increased in 2020, even despite COVID-19. Many of the workforce
that lost their jobs during 2020, many of them were put on furlough but still had their health benefits, so the enrolment within
HMO, as you&rsquo;re aware, in California, most of these HMO patients are then managed by medical groups through these capitated
contracts and we sub-capitate from these medical groups.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our revenue dollars are associated with
the number of enrollees in these programs, and because the number of enrollees was stable to slightly growing in 2020, our revenue
was up, not only because of the enrollees, but also because of some price increases that we have built into many of these contracts
on an annual basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Then furthermore, the incident of imaging,
meaning the use of imaging under these contracts, the utilization was significantly lower in 2020 so that the profitability of
our capitated contracts in 2020 was drastically up relative to prior years. It&rsquo;s really a great book of business, one that
we&rsquo;re looking to expand. We continually have conversations with new medical groups here in California, as well as taking
on and assuming the financial responsibility for more lives that might be part of other medical groups that we do contract with
here in California that have other geographies that we could potentially capitate for.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It&rsquo;s a business we like; we have
no costs of billing and collecting, we have very little patient bad debt, and we get paid in the month that we render the services
so that we have no cost of carrying receivables. It&rsquo;s really a unique part of our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay, no, that&rsquo;s great. Then quickly,
Mark, I don&rsquo;t know if you can help, but what&rsquo;s a good tax rate to use for 2021?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, 2020 was jumping all over, there were
lots of ins and outs related to transactions, so it&rsquo;s really hard to tell from 2020 what our effective tax rate is. If you
assume, for your modeling purposes, a federal tax rate of about 21% and a blended state tax rate of about 5%, so you get into the
26% to 27%, that&rsquo;s a good proxy for our tax provision. As you&rsquo;re probably aware, we&rsquo;re still burning off a pretty
substantial net operating loss carry-forward, so at least the federal part of that tax provision isn&rsquo;t paid in cash, but
it still hits our income statement with respect to our earnings per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay, thanks again for taking the questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You&rsquo;re welcome. Thanks, Mitra.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We&rsquo;ll go to our next question, from
John Ransom with Raymond James.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Jonathan Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I want to congratulate you guys on having
the shortest prepared remarks of any Company I cover, so you get the succinct award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Wait, say that again, John, we&rsquo;re
having a little trouble hearing you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Jonathan Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Oh. Sorry, is that better?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, that&rsquo;s better. Yes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Jonathan Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That&rsquo;s better. Yes, sorry, that&rsquo;s
better. I just wanted to give you guys the award for being the most succinct management team I cover in terms of your prepared
remarks, so congratulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Is that facetious or did we put you to
sleep?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Jonathan Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No, no, it&rsquo;s actually a compliment,
you guys are succinct. It&rsquo;s a sincere compliment. Just a few things, if we remember right, so DaVita Medical Group sold to
United, and that&rsquo;s a big, as you know, IPO group in California. Has having those practices in the hands of United, which
is probably more aggressive with rationalism (inaudible)&mdash;has that been part of the better pricing that you&rsquo;ve seen
in California, on the IPA contracts, or is that just a coincidence?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I don&rsquo;t think, at this point, John,
that it has translated into any additional benefit or opportunities for us. The marketplace here in California is not so much controlled
by United corporate, but really, here, the local Management and Officers here in California that we&rsquo;ve known for quite some
time. Even without United entering the picture, I think we had ongoing discussions with the various groups that have now been aggregated
under United into opportunities to further expand capitation. Maybe at some point there might be more of a national opportunity
that we would look at with United that could be&mdash;not only for capitation, but other fee-for-service businesses, particularly
in terms of mammography, that could be exciting for us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Jonathan Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. You guys obviously came through the
awfulness with flying colors, and this is&mdash;I&rsquo;m trying to find a glass half empty question, but don&rsquo;t take it the
wrong way. But being so exposed to California and New York, that were kind of extreme examples of lockdown states, did that cause
you to maybe rethink some of your geographic concentration, or are you thinking, &ldquo;Gosh, it couldn&rsquo;t get worse than
this, and look how well we did&rdquo;?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I get often asked the question, John, about
why we&rsquo;re only in five or six states, now actually a seventh with Arizona. But again, I make the analogy, for those of you
who are old enough or who have read widely about history, that when they caught the famous bank robber William Sutton, they asked
him why he robbed banks and he said, &ldquo;Because that&rsquo;s where the money is.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To some extent I think our strategy follows
along with that. While we can suffer through situations like we did here through the pandemic and the lockdowns, the fact of the
matter is that, if you combine the population of the United States that is in New York and New Jersey and in California, we&rsquo;re
probably talking, I&rsquo;m going to say, about a third of the population or somewhere in that area. I think we have to take the
good with the bad. There&rsquo;s seasonal issues that we get confronted with like we were in February with some inclement weather,
but it&rsquo;s where the people live, it&rsquo;s where the lives are. We&rsquo;re very much a volume-driven business and my preference
would be to stay in those markets where we can become the major outpatient player and benefit from large volumes and access to
our centers, which gives us some very unique contracting capabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Jonathan Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fine, okay, fair enough. Then lastly, can
you give an update, if any&mdash;we don&rsquo;t see a lot of portfolios trade in this business, but where do you think the private
equity/competitive strategic bid is for, let&rsquo;s say, a substantial plateful (phon) of assets versus where RadNet would be?
I mean, if the market can have a two to three times higher than you&rsquo;re willing to pay for, say, some other KPU (phon) with
a nice market and something like $20 million of EBITDA, are you going to be consistently outbid in those situations, just given
your history?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think we&rsquo;re aware of all the transactions
that go on in the imaging space, and we see the size of these transactions, not so much in terms of dollar amount, but in terms
of the multiples that people are paying. I think we look at each one of these in a very specific way. I think if a set of assets
were to come up that are very strategic for us, it would be worth taking a close look at those, even if they tended to be at higher
multiples than we may have paid in the past for. I think while that aggressive PD (phon) approach for acquiring some of these imaging
assets has been a bit of a head-scratcher for us, nonetheless, I think it helps define how valuable the RadNet strategy is, that
should have some of that benefit nevertheless in terms of our attractiveness to the stock market and shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">But I would say that we&rsquo;re more optimistic
about how we can continue to leverage our facilities, and that the consolidation&mdash;I know I&rsquo;m rambling here a little
bit, so I apologize, John. But consolidation is a major force inside of healthcare. I think there&rsquo;s no better poster child
for that than the imaging, particularly the outpatient imaging space. The leverage that we have with our platform gives us enormous
opportunities, many of which that we&rsquo;re working on this year to further create efficiencies and streamline our business.
Scaling up under the right circumstances is certainly something that we would be very serious about.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Jonathan Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sorry, one more I just forgot to ask you.
In your hospital JVs, I mean, your legacy was, gosh, unaffiliated freestanding centers are one-third, say, one-half the price of
what it would cost to get it done in a hospital. Of course, you pointed rightly, all the payors that are now steering people away
from hospital settings for routine scans. Will you do a joint venture with a hospital? I&rsquo;m assuming there is some contracting
work. Let&rsquo;s say the rate is, just make up a number, $1,500 for an MRI at the hospital and it&rsquo;s $400 at RadNet. Is the
hospital affiliation price $600 or is it a little better, a lot better, or how does that work? Considering, obviously, they have
more leverage with the payors that, say, RadNet would, in a given market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It varies from market to market. In some
markets, the relationship with the health system has in fact allowed us to get better rates than we would&rsquo;ve on a standalone
basis. But I think the primary benefit of the relationship with the health systems is not so much for rate lift. It&rsquo;s more
having a seat at the table with the relationship of the health system on a shoulder-to-shoulder basis, and where the health system
can actually drive volume into the outpatient centers, and that happens in two ways.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Number one, when the health insurers see
that we are joint ventured with a health system, they know that there is less of a necessity for them, meaning the health insurers,
on the pricing side of this, and that the health systems are shoulder-to-shoulder with us and helping drive the business away from
the hospitals into the outpatient centers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The other thing is that all of our health
systems, bar none, are in the business of acquisition of practices, physician practices. Once they&rsquo;re under the health system,
it&rsquo;s easier for them, particularly with the access that they get afforded with the RadNet locations, to direct that business
into the outpatient marketplace. Both of those benefits have been, I think, a very important part of our strategy with health system
joint ventures and have created benefits that we would not have enjoyed without them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Jonathan Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That&rsquo;s it for me, thanks so much.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All right, thanks, John. Stay safe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Jonathan Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes sir.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no further questions at this
time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Again, I would like to take this opportunity
to thank all of our shareholders for their continued support, and the employees of RadNet for their dedication and hard work. Our
Management will continue its endeavor to be a market leader that provides great services with an appropriate return on investment
for all stakeholders. Thank you for your time today, and I look forward to our next call. Stay safe and healthy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you for your participation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>rdnt-20210308.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOa6PiaPty552KYkxvmR3fVk6/yUmz/Y4NCMXY6AmEfcK -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:RDNT="http://radnet.com/20210308" elementFormDefault="qualified" targetNamespace="http://radnet.com/20210308">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://radnet.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20210308_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20210308_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>rdnt-20210308_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>rdnt-20210308_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://radnet.com/role/Cover" xlink:href="rdnt-20210308.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://radnet.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" !C .@# 2(  A$! Q$!_\0
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MQZ^(#?1CI%J,"L3_ -M$VG\P:TX+Z;A+ZU:V?^\&WQGZ-_B!5VDH *6D  &
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MKM-,\,:;I'VG[(L@^U($DW2$Y SC'IU-)I?A?3-'FFEM%E#3QB)]TA/RC/\
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M8.>HZ_SH M455.HV@<J9@",Y]B.M)_:5J8_,1S(N1RBDXSTH MT444 %%%%
M!4<L$4\?ERQJZ?W6&1110!62RMI+JX=X59LA<GGC:!C]:D_LZSX_T=. !T]*
M** ')96J1&)85"'&5QUQTIO]G681D^S1[6SD8X.<?X"BB@ _LZS.[_1X\.,-
MQU'^0*=]CMS*LODKO4 !L<C'2BB@!&L+5W+M A8YR<>O7^5"V%JKAU@0,.A
M]\T44 0_8K;[:B^2N(XOD'IS4HT^T (^SI@Y[>IS_2BB@"O>:?:16$I2W12J
M'!QTJ2&PM9((6>!681*H)YXQ110!7M["T&HW*>0NU%3:.PXJX-/LP /LZ8 P
M..W/^)HHH 5K&U>,1M I0# 'H,Y_G3?[-LA_R[1_>W=.]%% %'4+.VAEA,<*
MH3O)QQ_#5\V%K((R\",40(N1T'I110 #3[149!;H%9MQ&._K534]/M$L9'2!
M%8  $=N1110 E_8VL<,.R%5)F0$BKKV-K)(9'@5G)Y8CG_/ HHH &L;5R6:!
>"222<=SUIT5K!"0T<84A0HQZ#H*** )J*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>radnet_i8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdnt-20210308.xsd" xlink:type="simple"/>
    <context id="From2021-03-08to2021-03-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2021-03-08</startDate>
            <endDate>2021-03-08</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-03-08to2021-03-08">0000790526</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-03-08to2021-03-08">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-03-08to2021-03-08">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-03-08to2021-03-08">2021-03-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-03-08to2021-03-08">RadNet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-03-08to2021-03-08">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-03-08to2021-03-08">001-33307</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-03-08to2021-03-08">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-03-08to2021-03-08">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2021-03-08to2021-03-08">Los Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-03-08to2021-03-08">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-03-08to2021-03-08">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-03-08to2021-03-08">(310)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-03-08to2021-03-08">445-2800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-03-08to2021-03-08">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-03-08to2021-03-08">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-03-08to2021-03-08">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-03-08to2021-03-08">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-03-08to2021-03-08">Common Stock, $.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-03-08to2021-03-08">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-03-08to2021-03-08">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-03-08to2021-03-08">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140196993691832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 08, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  08,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RadNet,
Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(310)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">445-2800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.0001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ :Z-H4@=!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " !KHVA2DH7,@NT    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " !KHVA2F5R<(Q &  "<)P  $P
M        @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( &NC
M:%(UHS$G*P0  "$0   8              " @0P(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " !KHVA2@ZFE ]0!   R!@  #0
M        @ %M#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( &NC:%*7BKL<
MP    !,"   +              "  6P.  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( &NC:%*JQ"(6,P$  "("   /              "  54/  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " !KHVA2)!Z;HJT   #X 0  &@
M    @ &U$   >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" !KHVA299!YDAD!  #/ P  $P              @ &:$0  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "0 ) #X"  #D$@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="radnet_i8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://radnet.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="radnet_i8k.htm">radnet_i8k.htm</File>
    <File>radnet_ex9901.htm</File>
    <File>radnet_ex9902.htm</File>
    <File>rdnt-20210308.xsd</File>
    <File>rdnt-20210308_lab.xml</File>
    <File>rdnt-20210308_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "radnet_i8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "radnet_i8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20210308_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20210308_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20210308.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "RDNT",
   "nsuri": "http://radnet.com/20210308",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_i8k.htm",
      "contextRef": "From2021-03-08to2021-03-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://radnet.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_i8k.htm",
      "contextRef": "From2021-03-08to2021-03-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001683168-21-000815-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-21-000815-xbrl.zip
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M# DUU1OCQBU#PU\]HN/\">P+$?B 5+N+5!>.%GB$';V'%%8/^%E3H@$2 >D
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MEW!Y3M*RR=/,S9]4[<BB9G=\=#*'2SP PD"?$NCF([3VX%WC =DRE=JM-35
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MD7UM[/O3]^_>38-;R]0J]Z9Z;^H5T&;>84*OX;X#==SX69F.I__+U'^3@16
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M3[<8WQK#I/6V, 4O%<P0VUXM]PTS293$'ER8 JC7B-?]&QFN"UK R+154!J
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M5UQE ZOAY;W$X7!K'R1[C^A.<&L965!\G>L8EX\2([)")3F5H9BYB^?CLN!
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MNB8O+>G.V1;J6&\Y'M&#<\QW;<E0K4TA"ANWJ,U<)R6I2963][S<TJS27\D
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MI@50Y_PGS1^*;5'Q\C06ILMP?-U7R(N)SX"W#:HU-@M21KE>=LM.3#6_(4/
MPTC@<U9))$;F[SO>0W/<7)=&-%"DK.ENM^FNMJH*-NE$-8]'@FZ0F,_NTTA
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MH7'.'-YFE6]DE2XSW(-$=:(G%T4CHM0- H^M9FWI$.L&Z#^9%O9UOLZ3GP'
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M/)71@OYPZGZ7F^V1=-]VIX?',34&&5#'0;A] U%R2-S<>KL'_;L].._=[):
MQZUW._6Q(.8'N7=VUK_= J5L?$_0C?K>[I'M9K7@UK%([V:_V;0^_(;ZD0Y8
M3. _'/'%SON'R1S&V9$DQ^XAX Q'EQ?<6MQH2H.#;R$K&;J\W7![2N:VX^.E
M 5Q'\R^%<,H6[KL1LAP+D ?T&BNE?^BU%VTQH;B,+.H+:97N,W$=,R6.YQ
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M^CTF?!^(<AML-08CFJ["J2+C1 ^U>LO<36H\"@B.GC;GJ(GJ5P8ME=HSC_3
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M#(F%E?=!>RV1>D\.A62Z#8=QA(=L,DBA]*\^R^#[F,X-MZ[W92#CD;E9=(5
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MAX:OUK.\5%J)0#:H[I6:/*];X4=5TC$Z"D[4>[G_/5F@=JNMWGO.5B]EZKU
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MS<YYI!\GPBBZFP42\,G_VW5F(G;QJ8B]@X:8]@VKC'APEW80M\<T-HT^/-+
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M/E223! %JIUZ]>(9!P=^:V#1M'0.K@A2QTCC>65>X18B&A%G$&;2O8:+8/0
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M$MXBG!UM!P1+JY3@V[1*(.B K-A\P&-W,NY/&((3MQMA@5&#CC&.=I*KQ+?
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MD>NI-T#!'WF"3 ,F2M-O+,AA%G+(H"X'TW'-H-4I)J:!Z4%[T .@^LF+,[@
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M,#@N>'-DM59;;]HP%'[>I/T'+Z^3XP0&*Q1:5;U,J%=!6]&GR20.M4CLS':
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M5!GZT\(VP.PC+8#^Q9%#/-CWR)I"PO]XUCNCOWC(O#W0O#_RY]4>:NGC<J$
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M0X C&82:4?YQFK.(BV=>>YUBQK>R2=S/> R/7'JBW*(UJ A-P#I# L)LB$\
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MPZT]\C]02P$"% ,4    " !KHVA24KZYP8=*  #?40, $0
M@ $     <F%D;F5T7V5X.3DP,2YH=&U02P$"% ,4    " !KHVA2UU'-[EA-
M  !AG@$ $0              @ &V2@  <F%D;F5T7V5X.3DP,BYH=&U02P$"
M% ,4    " !KHVA2'C?9*$H2   B=   #@              @ $]F   <F%D
M;F5T7VDX:RYH=&U02P$"% ,4    " !KHVA2K]#E4S\#  "*#   $0
M        @ &SJ@  <F1N="TR,#(Q,#,P."YX<V102P$"% ,4    " !KHVA2
ME58)K/X*  #@AP  %0              @ $AK@  <F1N="TR,#(Q,#,P.%]L
M86(N>&UL4$L! A0#%     @ :Z-H4A-K&.Q5!P  ,5D  !4
M ( !4KD  ')D;G0M,C R,3 S,#A?<')E+GAM;%!+!08     !@ & '\!  #:
%P      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
